DRVN
Driven Brands Holdings Inc.
DRVN has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DRVN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
DRVN's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DRVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.8x | $11.53 | — |
| Current | 11x | $11.53 | — |
| Cheap | 14x | $14.15 | +23% |
| Fair | 120x | $125 | +981% |
| Expensive | 492x | $511 | +4335% |
Historical ranges are pointers, not guarantees.
DRVN's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 8.8x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DRVN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for DRVN, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DRVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.31 | +26% |
| Q2 2026 | $1.04 | +$2.74 |
| Q1 2026 | $1.12 | +$2.93 |
| Q4 2025 | $0.83 | +$2.65 |
| Q3 2025 | -$1.24 | -4233% |
| Q2 2025 | -$1.70 | +$3.01 |
| Q1 2025 | -$1.81 | +$2.86 |
| Q4 2024 | -$1.82 | +$2.71 |
| Q3 2024 | $0.03 | +$4.31 |
DRVN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DRVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $507.4M | -7.9% |
| Q1 2026 | $484.4M | -6.1% |
| Q4 2025 | $460.1M | -18% |
| Q3 2025 | $535.7M | -9.5% |
| Q2 2025 | $551M | -9.9% |
| Q1 2025 | $516.2M | -9.8% |
| Q4 2024 | $564.1M | +1.9% |
| Q3 2024 | $591.7M | +1.8% |
DRVN's revenue has slid since its 2024 peak: $507M last quarter, down 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +7.5 points |
| Q1 2026 | 14% | +2.1 points |
| Q4 2025 | 17% | +74 points |
| Q3 2025 | 12% | +4.9 points |
| Q2 2025 | 6.9% | -6.2 points |
| Q1 2025 | 12% | +1.6 points |
| Q4 2024 | -57% | -65 points |
| Q3 2024 | 6.7% | +163 points |
DRVN has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DRVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DRVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.9M | +221% |
| Q1 2026 | $23.1M | +22% |
| Q4 2025 | $36.2M | +$72.4M |
| Q3 2025 | $39.5M | +4.1% |
| Q2 2025 | $9M | +$28.5M |
| Q1 2025 | $18.9M | +$48.1M |
| Q4 2024 | -$36.3M | +$54.5M |
| Q3 2024 | $37.9M | +$103M |
DRVN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DRVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +299K shares |
| 1 year | +0.5% | +786K shares |
| 3 years | -1.2% | -2M shares |
| 5 years | -0.9% | -1.6M shares |
| Available history | -0.7% | -1.1M shares |
DRVN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $49.2M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
DRVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 5.6x | High |
| Q1 2025 | 71.8x | High |
| Q4 2024 | 63.3x | High |
| Q3 2024 | 6.4x | High |
| Q2 2023 | 5.2x | High |
| Q1 2023 | 7.5x | High |
DRVN's net debt is about 4.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DRVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 28.0 | Neutral |
DRVN's weekly RSI is 42 (neutral) and its Stochastic is 28 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DRVN PE vs Consumer Cyclical Sector
| Metric | DRVN | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 0 | 50 | 50 pts below |
DRVN is trading at 11x earnings, a 38% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DRVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 3.1% below |
| 20 week MA | $12.9 | 11% below |
| 50 week MA | $13.5 | 14% below |
| 100 week MA | $15.0 | 23% below |
| 200 week MA | $16.3 | 29% below |
DRVN is in a downtrend: it's below all five of its weekly moving averages, and 29% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DRVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.7 | $33.3 | +25% |
| 2022 | $33.3 | $26.8 | -20% |
| 2023 | $26.8 | $14.3 | -47% |
| 2024 | $14.3 | $16.2 | +14% |
| 2025 | $16.2 | $14.8 | -8.6% |
| 2026 YTD | $14.8 | $11.5 | -22% |
DRVN has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.